Edition:
United States

Rxi Pharmaceuticals Corp (RXII.OQ)

RXII.OQ on NASDAQ Stock Exchange Capital Market

3.34USD
23 Feb 2018
Change (% chg)

$-0.09 (-2.62%)
Prev Close
$3.43
Open
$3.51
Day's High
$3.51
Day's Low
$3.15
Volume
14,355
Avg. Vol
11,219
52-wk High
$11.20
52-wk Low
$3.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -1.053
Jun '17 0.00 -1.123
Mar '17 0.00 -2.654
FY 2016 Dec '16 0.00 -6.015
Sep '16 0.00 -3.364
Jun '16 0.01 -3.385
Mar '16 0.01 -3.414
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 195.87 33.62
P/E High - Last 5 Yrs. -- 285.81 46.17
P/E Low - Last 5 Yrs. -- 93.64 24.19
Beta 1.59 0.81 0.81
Price to Sales (TTM) -- 137.83 8.35
Price to Book (MRQ) 2.31 20.52 5.22
Price to Tangible Book (MRQ) 2.31 28.04 6.44
Price to Cash Flow (TTM) -- 128.31 25.88
% Owned Institutions 2.25 11.86 2.30

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.23
Payout Ratio(TTM) -- 8.14 41.36

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 64.95 9.76
Sales (TTM) vs TTM 1 Yr. Ago -100.00 58.16 7.57
Sales - 5 Yr. Growth Rate -- 33.63 10.22
EPS (MRQ) vs Qtr. 1 Yr. Ago 68.69 -94.99 16.24
EPS (TTM) vs TTM 1 Yr. Ago 23.40 -- --
EPS - 5 Yr. Growth Rate -- 46.89 11.55
Capital Spending - 5 Yr. Growth Rate -41.62 43.77 14.75

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.42
Current Ratio (MRQ) 2.20 6.12 3.39
LT Debt to Equity (MRQ) 0.00 16.21 12.39
Total Debt to Equity (MRQ) 0.00 18.27 15.84
Interest Coverage (TTM) -- -156.52 38.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.30 54.79
Gross Margin - 5 Yr. Avg. -- 55.30 52.59
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -9,925.65 -230.69 14.70
Operating Margin (TTM) -- -487.70 4.10
Operating Margin - 5 Yr. Avg. -10,000.32 -247.29 9.99
Pre-Tax Margin (TTM) -- -463.92 4.83
Pre-Tax Margin - 5 Yr. Avg. -9,971.29 -253.91 10.24
Net Profit Margin (TTM) -- -445.10 1.55
Net Profit Margin - 5 Yr. Avg. -9,971.29 -257.36 6.54
Effective Tax Rate (TTM) -- 0.46 21.93
Effective Tax Rate - 5 Yr. Avg. -- 17.72 24.14

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,863,557 817,554,851
Net Income/Employee (TTM) -852,600 -520,338 95,586,843
Receivable Turnover (TTM) -- 13.83 5.44
Inventory Turnover (TTM) -- 2.38 3.52
Asset Turnover (TTM) 0.00 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -233.93 -1.04 10.73
Return on Assets - 5 Yr. Avg. -127.67 -0.14 12.03
Return on Investment (TTM) -395.58 -0.71 13.63
Return on Investment - 5 Yr. Avg. -158.90 2.18 15.76
Return on Equity (TTM) -459.76 -3.37 15.39
Return on Equity - 5 Yr. Avg. -855.83 -1.91 17.03
  1 Year 3 Year 5 Year
Sales % -44.12 -63.75 --
EPS (TTM) % 21.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Rxi Pharmaceuticals Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -17.53 -13.76 31 77
13 Week -50.81 -53.40 8 94
26 Week -42.01 -48.44 21 91
52 Week -52.46 -59.09 30 89
YTD -39.91 -41.52 9 92
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.25%
# of Holders: 16
Total Shares Held: 53,205
3 Mo. Net Change: -3,346
# New Positions: 4
# Closed Positions: 3
# Increased Positions: 7
# Reduced Positions: 7
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.